ALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALVR WHY: ...
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the posoleucel Phase 3 Studies were ...
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of AlloVir, Inc. (NASDAQ: ALVR) and Kalaris Therapeutics is fair to AlloVir shareholders.
Alvarion (NASDAQ:ALVR): Q1 EPS of -$0.51. Revenue of $8.5M (-45.4% Y/Y). (PR) ...
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of AlloVir, Inc. ...
EMCORE Corporation (NASDAQ: EMKR), relating to its proposed merger with Velocity One Holdings, LP. Under the terms of the agreement, EMCORE stockholders will receive $3.10 per share of EMCORE common ...
AlloVir (NASDAQ:ALVR) just reported results for the first quarter of 2024. AlloVir reported earnings per share of -26 cents. This was below the analyst estimate for EPS of -18 cents. The company did ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results